NeoStem gets grant for Scleroderma research

|By:, SA News Editor

NeoStem (NBS +6.4%) jumps after saying the National Institute of Arthritis and Musculoskeletal and Skin Diseases has awarded the company nearly $148K for the "Development of Adult Pluripotent VSEL stem cells to treat skin wounds in Scleroderma."

Depending on the results of the study (which will employ a tight skin mouse), the company may be eligible to receive an additional $1.5M in grants. (PR)